EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Assessing Agreement of Repeated Binary Measurements with an Application to the CDC’s Anthrax Vaccine Clinical Trial

Yi Pan, Charles E Rose, Michael Haber, Yan Ma, Josep L Carrasco, Brock Stewart, Wendy A Keitel, Harry Keyserling, Robert M Jacobson, Gregory Poland, Michael M McNeil

ijb · 2013

DOI: 10.1515/ijb-2012-0001 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift ijb, 2013. Verfasst von Yi Pan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Dise…. Hauptthemen laut MEDLINE: Data Interpretation, Statistical, Models, Statistical. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cohen’s kappa coefficient, which was introduced in 1960, serves as the most widely employed coefficient to assess inter-observer agreement for categorical outcomes. However, the original kappa can only be applied to cross-sectional binary measurements and, therefore, cannot be applied in the practical situation when the observers evaluate the same subjects at repeated time intervals. This study summarizes six methods of assessing agreement of repeated binary outcomes under different assumptions and discusses under which condition we should use the most appropriate method in practice. These approaches are illustrated using data from the CDC anthrax vaccine adsorbed (AVA) human clinical trial comparing the agreement for two solicited adverse events after AVA between the 1–3 day in-clinic medical record and the patient’s diary on the same day. We hope this article can inspire researchers to choose the most appropriate method to assess agreement for their own study with longitudinal binary data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Data Interpretation, StatisticalModels, StatisticalAdultAnthraxAnthrax VaccinesCenters for Disease Control and Prevention, U.S.Clinical Trials as TopicFemaleHumansLongitudinal StudiesMaleMiddle AgedUnited States

Substanzen

Anthrax Vaccines

Autor:innen und Institutionen

  • Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. jun5@cdc.gov

Förderung

  • Intramural CDC HHS

Zitieren

APA

Pan, Y., Rose, C. E., Haber, M., Ma, Y., Carrasco, J. L., Stewart, B., Keitel, W. A., Keyserling, H., Jacobson, R. M., Poland, G., & McNeil, M. M. (2013). Assessing Agreement of Repeated Binary Measurements with an Application to the CDC’s Anthrax Vaccine Clinical Trial. ijb. https://doi.org/10.1515/ijb-2012-0001

Vancouver

Pan Y, Rose CE, Haber M, Ma Y, Carrasco JL, Stewart B, et al. Assessing Agreement of Repeated Binary Measurements with an Application to the CDC’s Anthrax Vaccine Clinical Trial. ijb. 2013. doi:10.1515/ijb-2012-0001

BibTeX
@article{Pan2013,
  author = {Pan, Yi and Rose, Charles E and Haber, Michael and Ma, Yan and Carrasco, Josep L and Stewart, Brock and Keitel, Wendy A and Keyserling, Harry and Jacobson, Robert M and Poland, Gregory and McNeil, Michael M},
  title = {Assessing Agreement of Repeated Binary Measurements with an Application to the CDC’s Anthrax Vaccine Clinical Trial},
  journal = {ijb},
  year = {2013},
  doi = {10.1515/ijb-2012-0001}
}
Kostenlos starten →